Anorectal Function in Perianal Crohn's Disease

February 24, 2020 updated by: The Leeds Teaching Hospitals NHS Trust

Evaluation of Anorectal Function in Perianal Crohn's Disease: a Pilot Study.

Perianal Crohn's disease is a disabling disease associated with increased morbidity and impaired quality of life. It is associated with pain, discharge, fecal incontinence and sexual and psychological impairment. In refractory cases, a stoma may be necessary. A higher prevalence is seen with increasing Crohn's disease duration and appears to vary according to the disease location. The presence of symptoms associated with anorectal dysfunction, such as fecal incontinence, can sometimes poorly correlate with the presence of anal sphincter abnormalities. Moreover, even in patients without symptoms, the presence of anal sphincter abnormalities may have important implications for the future selection of type of delivery, and might even pose a contra-indication for certain types of anorectal surgeries.

Studies evaluating possible chronic complications of perianal Crohn's disease on anorectal function are lacking. There is a need for a better understanding of the chronic complications of this disease, and the role of high-resolution anorectal manometry in diagnosing these abnormalities during follow-up of these patients. This study will evaluate the chronic repercussions of perianal Crohn's disease in patients with a previous anal fistula and/or abscess that has healed and/or is inactive.

Study Overview

Study Type

Observational

Enrollment (Actual)

16

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leeds, United Kingdom, LS7 4SA
        • Leeds Teaching Hospital NHS Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients attending hospital with diagnosed perianal Crohn's disease.

Description

Inclusion Criteria:

  1. ≥ 18 and ≤ 75 year-old patients
  2. CD in clinical remission, defined by a Harvey-Bradshaw index <5
  3. Perianal CD history, defined by the presence of a perianal fistula and/or abscess that were treated/heal/inactive
  4. Perianal Disease Activity Index (PDAI) of ≤4
  5. Asymptomatic or symptomatic patients (anorectal symptoms) will be included, as long they fulfill the other inclusion criteria, like for anorectal symptomatic patients having a PDAI≤4
  6. Endoanal ultrasound without an image compatible with new/non-treated abscess or perianal fistula
  7. Both previous simple or complex perianal fistula (according to the American College of Gastroenterology) will be considered.

Exclusion Criteria:

  1. Women with previous vaginal delivery
  2. Ileostomy
  3. Previous anorectal surgery as hemorrhoidectomy or lateral sphincterotomy
  4. Active rectal disease. No rectal involvement will be defined by no previous rectal involvement ever described or if previous involvement, endoscopy within 18 months showing no current involvement
  5. Previous or current anal fissure
  6. Anal stricture
  7. Current or previous rectovaginal fistula (previous/last pelvic MRI).

A previous seton placement, abscess drainage, fistulotomy and lay open fistula are not an exclusion criteria. Patients with a current seton can only be included if the seton was place more than 24 weeks ago, and the endoanal ultrasound does not show any new/non-treated perianal fistula/abscess.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients with perianal Crohn's disease.
For the assessment of the internal and external anal sphincter integrity. To evaluate fistulas/perianal abscess and seton placement.
  1. rest - basal anal pressures at rest over 60 s
  2. squeeze - anal pressure during voluntary effort; long squeeze - anal pressure during sustained voluntary effort
  3. cough - anorectal pressure changes during cough
  4. push - anorectal pressure changes during simulated defecation
  5. rectoanal inhibitory reflex - reflex anal response to rectal distension
  6. rectal sensation - assessment of rectal sensitivity to distension.
A non-latex balloon will be inserted in the rectum after applying lubricating gel. This balloon is then filled with 50ml of warm water. The patient is ask to sit on a commode and to try to expel the device in privacy, while the time is being recorded. The test ends when the patient expelled the balloon or when 3 minutes are reach.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Resting pressure, squeezing pressure, anorectal pressure changes during cough, anorectal pressure changes during simulated defecation, presence of a rectoanal inhibitory reflex and assessment of rectal sensitivity to distension.
Time Frame: 30 minutes
Evaluated by high-resolution anorectal manometry.
30 minutes
Anal sphincters integrity.
Time Frame: 5 minutes
Evaluated by endoanal ultrasound.
5 minutes
Ballon expulsion test duration.
Time Frame: 3 minutes
3 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Presence of symptoms suggesting obstructed defection.
Time Frame: 5 minutes
Prolonged and unsuccessful straining at stool, self-digitation for defecation, sense of incomplete evacuation or sensation of anorectal obstruction/blockage and a stool frequency of less than three times per week.
5 minutes

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wexner score (fecal incontinence score).
Time Frame: 5 minutes
5 items score, including solid, liquid, gas incontinence, wearing pads and lifestyle alterations, scored from 0 (normal) to 4 (more severe).
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 19, 2019

Primary Completion (ACTUAL)

February 22, 2020

Study Completion (ACTUAL)

February 22, 2020

Study Registration Dates

First Submitted

January 18, 2019

First Submitted That Met QC Criteria

January 25, 2019

First Posted (ACTUAL)

January 28, 2019

Study Record Updates

Last Update Posted (ACTUAL)

February 25, 2020

Last Update Submitted That Met QC Criteria

February 24, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Crohn Disease

Clinical Trials on Endoanal ultrasound

3
Subscribe